Search

Author/Creator Meeldijk, Jan

2. Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting. Issue 1 (2nd January 2016)

Authors:
Meyer, Saskia; Nederend, Maaike; Jansen, J.H. Marco; Reiding, Karli R.; Jacobino, Shamir R.; Meeldijk, Jan; Bovenschen, Niels; Wuhrer, Manfred; Valerius, Thomas; Ubink, Ruud; Boross, Peter; Rouwendal, Gerard; Leusen, Jeanette H.W.
Journal:
MAbs
Issue:
Volume 8:Issue 1(2016)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo. Issue 3 (3rd April 2018)

Authors:
Jacobino, Shamir R.; Nederend, Maaike; Reijneveld, J. Frederiek; Augustijn, Daan; Jansen, J. H. Marco; Meeldijk, Jan; Reiding, Karli R.; Wuhrer, Manfred; Coenjaerts, Frank E. J.; Hack, C. Erik; Bont, Louis J.; Leusen, Jeanette H. W.
Journal:
MAbs
Issue:
Volume 10:Issue 3(2018)
Page Start:
453
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Serpin B9 controls tumor cell killing by CAR T cells. Issue 3 (17th March 2023)

Authors:
Kimman, Thomas; Slomp, Anne; Martens, Anne; Grabherr, Sarah; Li, Shuang; van Diest, Eline; Meeldijk, Jan; Kuball, Jurgen; Minnema, Monique C; Eldering, Eric; Bovenschen, Niels; Sebestyén, Zsolt; Peperzak, Victor
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗